Literature DB >> 7562825

Caffeine dependence: fact or fiction?

E C Strain1, R R Griffiths.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7562825      PMCID: PMC1295296     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  16 in total

1.  Low-dose caffeine discrimination and self-reported mood effects in normal volunteers.

Authors:  K Silverman; R R Griffiths
Journal:  J Exp Anal Behav       Date:  1992-01       Impact factor: 2.468

2.  Low-dose caffeine physical dependence in humans.

Authors:  R R Griffiths; S M Evans; S J Heishman; K L Preston; C A Sannerud; B Wolf; P P Woodson
Journal:  J Pharmacol Exp Ther       Date:  1990-12       Impact factor: 4.030

3.  A survey of physician advice about caffeine.

Authors:  J R Hughes; G Amori; D K Hatsukami
Journal:  J Subst Abuse       Date:  1988

4.  Psychotropic effects of caffeine in man. 3. A questionnaire survey of coffee drinking and its effects in a group of housewives.

Authors:  A Goldstein; S Kaizer
Journal:  Clin Pharmacol Ther       Date:  1969 Jul-Aug       Impact factor: 6.875

5.  Withdrawal syndrome after the double-blind cessation of caffeine consumption.

Authors:  K Silverman; S M Evans; E C Strain; R R Griffiths
Journal:  N Engl J Med       Date:  1992-10-15       Impact factor: 91.245

6.  Effects of caffeine, theophylline and theobromine on scheduled controlled responding in rats.

Authors:  J M Carney
Journal:  Br J Pharmacol       Date:  1982-03       Impact factor: 8.739

7.  The influence of chronic caffeine administration on sleep parameters in the cat.

Authors:  C M Sinton; F Petitjean
Journal:  Pharmacol Biochem Behav       Date:  1989-02       Impact factor: 3.533

8.  Caffeine dependence syndrome. Evidence from case histories and experimental evaluations.

Authors:  E C Strain; G K Mumford; K Silverman; R R Griffiths
Journal:  JAMA       Date:  1994-10-05       Impact factor: 56.272

9.  Behavioral dependence on caffeine and phencyclidine in rhesus monkeys: interactive effects.

Authors:  M E Carroll; E W Hagen; M Asencio; L H Brauer
Journal:  Pharmacol Biochem Behav       Date:  1988-12       Impact factor: 3.533

10.  Evidence for withdrawal from caffeine by rats.

Authors:  M V Vitiello; S C Woods
Journal:  Pharmacol Biochem Behav       Date:  1977-05       Impact factor: 3.533

View more
  6 in total

Review 1.  Insufficient sleep in adolescents and young adults: an update on causes and consequences.

Authors:  Judith Owens
Journal:  Pediatrics       Date:  2014-09       Impact factor: 7.124

2.  Caffeine Induces a Stimulant Effect and Increases Dopamine Release in the Nucleus Accumbens Shell Through the Pulmonary Inhalation Route of Administration in Rats.

Authors:  Martín Galvalisi; José Pedro Prieto; Marcela Martínez; Juan Andrés Abin-Carriquiry; Cecilia Scorza
Journal:  Neurotox Res       Date:  2016-09-08       Impact factor: 3.911

3.  Caffeine, a common active adulterant of cocaine, enhances the reinforcing effect of cocaine and its motivational value.

Authors:  José Pedro Prieto; Cecilia Scorza; Gian Pietro Serra; Valentina Perra; Martín Galvalisi; Juan Andrés Abin-Carriquiry; Giovanna Piras; Valentina Valentini
Journal:  Psychopharmacology (Berl)       Date:  2016-06-07       Impact factor: 4.530

Review 4.  Licit and illicit drug use in cluster headache.

Authors:  Amelie Govare; Elizabeth Leroux
Journal:  Curr Pain Headache Rep       Date:  2014-05

Review 5.  Craving espresso: the dialetics in classifying caffeine as an abuse drug.

Authors:  Max Kenedy Felix Dos Santos; Elaine C Gavioli; Lorena Santa Rosa; Vanessa de Paula Soares-Rachetti; Bruno Lobão-Soares
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-10-18       Impact factor: 3.000

6.  Genome-wide association analysis of coffee drinking suggests association with CYP1A1/CYP1A2 and NRCAM.

Authors:  N Amin; E Byrne; J Johnson; G Chenevix-Trench; S Walter; I M Nolte; J M Vink; R Rawal; M Mangino; A Teumer; J C Keers; G Verwoert; S Baumeister; R Biffar; A Petersmann; N Dahmen; A Doering; A Isaacs; L Broer; N R Wray; G W Montgomery; D Levy; B M Psaty; V Gudnason; A Chakravarti; P Sulem; D F Gudbjartsson; L A Kiemeney; U Thorsteinsdottir; K Stefansson; F J A van Rooij; Y S Aulchenko; J J Hottenga; F R Rivadeneira; A Hofman; A G Uitterlinden; C J Hammond; S-Y Shin; A Ikram; J C M Witteman; A C J W Janssens; H Snieder; H Tiemeier; B H R Wolfenbuttel; B A Oostra; A C Heath; E Wichmann; T D Spector; H J Grabe; D I Boomsma; N G Martin; C M van Duijn
Journal:  Mol Psychiatry       Date:  2011-08-30       Impact factor: 15.992

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.